Literature DB >> 11467446

The ras signaling pathway in mammary tumorigenesis and metastasis.

S Malaney1, R J Daly.   

Abstract

The Ras superfamily of GTPases act as important regulatory switches to co-ordinate extracellular stimuli with activation of intracellular signaling pathways and appropriate biological responses. The Ras branch of this superfamily includes H-, K- and N-Ras, which are commonly mutated in particular human cancers, but notably not in those of the breast. Instead, in breast cancer the signaling pathways involving these GTPases may be upregulated due to increased coupling to growth factor receptors or other tyrosine kinases commonly overexpressed in this disease, or increased expression of regulators, the Ras protein itself, or downstream effectors. Functional studies utilizing both in vitro and in vivo models demonstrate that Ras signaling can regulate a variety of endpoints relevant to breast cancer progression, including anchorage dependent and independent growth, tumorigenesis, steroid sensitivity and invasion. Finally, analysis of the processing and signaling mechanisms of the Ras superfamily has identified potential targets for therapeutic intervention.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11467446     DOI: 10.1023/a:1009572700317

Source DB:  PubMed          Journal:  J Mammary Gland Biol Neoplasia        ISSN: 1083-3021            Impact factor:   2.698


  72 in total

Review 1.  Rho GTPases and signaling networks.

Authors:  L Van Aelst; C D'Souza-Schorey
Journal:  Genes Dev       Date:  1997-09-15       Impact factor: 11.361

2.  H-ras induced transformation of mammary epithelium is favoured by increased oncogene expression or by inhibition of mammary regression.

Authors:  A C Andres; O Bchini; B Schubaur; B Dolder; M LeMeur; P Gerlinger
Journal:  Oncogene       Date:  1991-05       Impact factor: 9.867

3.  Grb2 mediates the EGF-dependent activation of guanine nucleotide exchange on Ras.

Authors:  N W Gale; S Kaplan; E J Lowenstein; J Schlessinger; D Bar-Sagi
Journal:  Nature       Date:  1993-05-06       Impact factor: 49.962

4.  Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer.

Authors:  D J Slamon; W Godolphin; L A Jones; J A Holt; S G Wong; D E Keith; W J Levin; S G Stuart; J Udove; A Ullrich
Journal:  Science       Date:  1989-05-12       Impact factor: 47.728

5.  Accelerated mammary tumor development in mutant polyomavirus middle T transgenic mice expressing elevated levels of either the Shc or Grb2 adapter protein.

Authors:  M J Rauh; V Blackmore; E R Andrechek; C G Tortorice; R Daly; V K Lai; T Pawson; R D Cardiff; P M Siegel; W J Muller
Journal:  Mol Cell Biol       Date:  1999-12       Impact factor: 4.272

6.  Differential expression and mutation of the ras family genes in human breast cancer.

Authors:  S Miyakis; G Sourvinos; D A Spandidos
Journal:  Biochem Biophys Res Commun       Date:  1998-10-20       Impact factor: 3.575

7.  Molecular cloning of the mouse grb2 gene: differential interaction of the Grb2 adaptor protein with epidermal growth factor and nerve growth factor receptors.

Authors:  K L Suen; X R Bustelo; T Pawson; M Barbacid
Journal:  Mol Cell Biol       Date:  1993-09       Impact factor: 4.272

8.  Expression of the neu protooncogene in the mammary epithelium of transgenic mice induces metastatic disease.

Authors:  C T Guy; M A Webster; M Schaller; T J Parsons; R D Cardiff; W J Muller
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-15       Impact factor: 11.205

9.  Direct mutagenesis of Ha-ras-1 oncogenes by N-nitroso-N-methylurea during initiation of mammary carcinogenesis in rats.

Authors:  H Zarbl; S Sukumar; A V Arthur; D Martin-Zanca; M Barbacid
Journal:  Nature       Date:  1985 May 30-Jun 5       Impact factor: 49.962

10.  Targeted c-myc gene expression in mammary glands of transgenic mice induces mammary tumours with constitutive milk protein gene transcription.

Authors:  C A Schoenenberger; A C Andres; B Groner; M van der Valk; M LeMeur; P Gerlinger
Journal:  EMBO J       Date:  1988-01       Impact factor: 11.598

View more
  26 in total

1.  Altered glucose metabolism in Harvey-ras transformed MCF10A cells.

Authors:  Wei Zheng; Fariba Tayyari; G A Nagana Gowda; Daniel Raftery; Eric S McLamore; D Marshall Porterfield; Shawn S Donkin; Brian Bequette; Dorothy Teegarden
Journal:  Mol Carcinog       Date:  2013-09-02       Impact factor: 4.784

2.  Conditional expression of Ki-RasG12V in the mammary epithelium of transgenic mice induces estrogen receptor alpha (ERα)-positive adenocarcinoma.

Authors:  S Andò; R Malivindi; S Catalano; P Rizza; I Barone; S Panza; D Rovito; C Emprou; J-M Bornert; G Laverny; D Metzger
Journal:  Oncogene       Date:  2017-07-24       Impact factor: 9.867

3.  Prevention of carcinogenesis and inhibition of breast cancer tumor burden by dietary stearate.

Authors:  Chuanyu Li; Xiangmin Zhao; Eric C Toline; Gene P Siegal; Lynda M Evans; Arig Ibrahim-Hashim; Renee A Desmond; Robert W Hardy
Journal:  Carcinogenesis       Date:  2011-05-17       Impact factor: 4.944

4.  Phosphorylation of serine 68 of Twist1 by MAPKs stabilizes Twist1 protein and promotes breast cancer cell invasiveness.

Authors:  Jun Hong; Jian Zhou; Junjiang Fu; Tao He; Jun Qin; Li Wang; Lan Liao; Jianming Xu
Journal:  Cancer Res       Date:  2011-04-18       Impact factor: 12.701

5.  Igf1r as a therapeutic target in a mouse model of basal-like breast cancer.

Authors:  Apostolos Klinakis; Matthias Szabolcs; Guoying Chen; Shouhong Xuan; Hanina Hibshoosh; Argiris Efstratiadis
Journal:  Proc Natl Acad Sci U S A       Date:  2009-01-27       Impact factor: 11.205

6.  HOXB9, a gene overexpressed in breast cancer, promotes tumorigenicity and lung metastasis.

Authors:  Tetsu Hayashida; Fumiyuki Takahashi; Naokazu Chiba; Elena Brachtel; Motomi Takahashi; Nadia Godin-Heymann; Kenneth W Gross; Maria d M Vivanco; Vasuki Wijendran; Toshihiro Shioda; Dennis Sgroi; Patricia K Donahoe; Shyamala Maheswaran
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-28       Impact factor: 11.205

7.  Mechanisms of disease: epithelial-mesenchymal transition--does cellular plasticity fuel neoplastic progression?

Authors:  Eva A Turley; Mandana Veiseh; Derek C Radisky; Mina J Bissell
Journal:  Nat Clin Pract Oncol       Date:  2008-03-18

8.  Regulation of C/EBPbeta1 by Ras in mammary epithelial cells and the role of C/EBPbeta1 in oncogene-induced senescence.

Authors:  A A Atwood; L Sealy
Journal:  Oncogene       Date:  2010-09-06       Impact factor: 9.867

9.  The Ras-GRF1 exchange factor coordinates activation of H-Ras and Rac1 to control neuronal morphology.

Authors:  Huibin Yang; Raymond R Mattingly
Journal:  Mol Biol Cell       Date:  2006-02-15       Impact factor: 4.138

10.  Pathway pathology: histological differences between ErbB/Ras and Wnt pathway transgenic mammary tumors.

Authors:  Andrea Rosner; Keiko Miyoshi; Esther Landesman-Bollag; Xin Xu; David C Seldin; Amy R Moser; Carol L MacLeod; G Shyamala; Amy E Gillgrass; Robert D Cardiff
Journal:  Am J Pathol       Date:  2002-09       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.